Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Regulatory decisions and consumers.

M D Rawlins

    Medical Toxicology
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Regulatory bodies assess non-narcotic analgesics for safety and effectiveness pre- and post-market. They utilize adverse drug reaction (ADR) reporting to monitor drug toxicity and identify risks in consumers.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Interdose control of beta-blockade and arterial blood pressure during chronic oral labetalol treatment.

    British journal of clinical pharmacology·2015
    Same author

    A comparative study of methyldopa and labetalol in the treatment of hypertension.

    British journal of clinical pharmacology·2015
    Same author

    Mean steady-state plasma concentrations of labetalol in patients undergoing antihypertensive therapy.

    British journal of clinical pharmacology·2015
    Same author

    A multicentre open trial of labetalol in New Zealand.

    British journal of clinical pharmacology·2015
    Same author

    Spontaneous reporting of fatal adverse drug reactions.

    The International journal of risk & safety in medicine·2013
    Same author

    Clinical pharmacology in the National Health Service.

    Journal of the Royal Society of Medicine·2010

    Area of Science:

    • Pharmacovigilance
    • Drug Safety Evaluation
    • Regulatory Science

    Background:

    • Consumers expect rigorous evaluation of non-narcotic analgesics by regulatory authorities.
    • Ensuring drug quality, efficacy, and safety is paramount before and after market release.

    Purpose of the Study:

    • To outline the regulatory processes for evaluating non-narcotic analgesics.
    • To describe the methods used for post-marketing surveillance of drug safety.

    Main Methods:

    • Pre-marketing assessment of drug quality, efficacy, and toxicological hazards.
    • Post-marketing surveillance utilizing spontaneous adverse drug reaction (ADR) reporting systems.

    Main Results:

    • Regulatory authorities ensure products meet quality and efficacy standards before approval.

    Related Experiment Videos

  • Adverse drug reaction reporting systems are crucial for identifying post-marketing risks and toxicity.

    • Conclusions:

    • Regulatory oversight is essential throughout a drug's lifecycle.
    • Adverse drug reaction data collection aids in identifying risk factors and ensuring public health.
    • Continuous monitoring is key to managing drug safety effectively.